ABSTRACT. The antimicrobial susceptibility of 201 Listeria monocytogenes isolates from foods, environments, animals and human patients in Japan was determined. All isolates were susceptible to ampicillin, the first choice of drug for listeriosis treatment, chloramphenicol, dihydrostreptomycin, erythromycin, enrofloxacin, gentamicin, kanamycin, lincomycin, nosiheptide, salinomycin, vancomycin, and virginiamycin. A human strain was resistant to oxytetracycline. The Minimum Inhibitory Concentration (MIC) for 50% of the strains and the MIC for 90% of the strains were comparable in all the isolates. This is the first investigation to compare antibiotic resistances between isolates from foods and isolates from human patients in Japan. The result showed that most of the isolates were susceptible to antibiotics used in this study.
*, Akiko OKUTANI 1) **, Hodaka SUZUKI 1) , Hiroshi ASAKURA 1) , Shuko MONDEN 1) , Akiko NAKAMA 2) , Tsutomu MARUYAMA 3) and Shizunobu IGIMI 2) Listeria monocytogenes causes listeriosis, a severe disease which can lead to abortion, stillbirth, and meningoencephalitis in human and animals. Contaminated foods are the main causative agents for humans. Many outbreaks of human listeriosis have been reported in the U.S.A. and European countries. In Japan, the case numbers of human listeriosis have been remained relatively low [11] ; nevertheless, the contamination rates of retail foods are at similar levels to those in the U.S.A. and Europe [12] . To date, most cases of human listeriosis in Japan are sporadic, and only one recognized foodborne outbreak has been reported [9] . Antimicrobial drugs have been used routinely to treat listeriosis in humans and animals. The resistant isolates against ampicillin (ABPC), the drug of first choice for treatment in many cases, began to be observed from 1984 [13] . Previous researches suggested that veterinary use of antibiotics may cause increased resistance in human pathogens via food exposure (reviewed by [10] ). However, there have been very few studies on antibiotic resistance of L. monocytogenes isolated from foods in Japan [7] , and most studies were performed with small numbers of isolates from sporadic cases of human or animal listeriosis [16, 17, 19, 20] . In this study, we investigated the susceptibility of 201 isolates to 3 categories of antibiotics: (1) antibiotics used for the treatment of human bacterial infection, (2) antibiotics used for livestock, to determine the level of diffusion of resistance via dairy and fishery products, and other types of food, to humans, and (3) antibiotics used as feed additives. Antibiotic feed additives are supplemented to animal feed continuously at low concentrations to increase animal growth. Use of feed additives is permitted in Japan and some Asian countries; however, the EU has banned the use of antibiotics as growth promoters. There are no reports of susceptibility of L. monocytogenes to these antibiotics. Therefore, we investigated the susceptibility to feed additives to assess the influence of continuous antibiotic use during livestock fattening phases on bacterial susceptibilities.
L. monocytogenes isolates are listed in Table 1 . One hundred and one isolates were from human patients of listeriosis, and 100 isolates were from foods, the environment, and animals (collectively called as FE isolates in this study). The sources of these latter isolates were as follows: 93 isolates from foods; 1 isolate from a cow with listeriosis; 1 isolate from feces of a cow, and 5 isolates from the environments for food-processing, such as a refrigerator and cutting boards. All isolates were obtained in Japan from Susceptibilities of all isolates were tested against 13 different antibiotics. The antibiotics were selected from a wide range of those used as medication for humans and animals or as feed additives. ABPC (Wako Chemicals, Osaka, Japan), chloramphenicol (CP; Wako), erythromycin (EM; Sigma, St. Louis, MO, U.S.A.), gentamicin (GM; Sigma), kanamycin (KM; Wako), lincomycin (LCM), and vancomycin (VCM) are major antibiotics used for human bacterial infection. Dihydrostreptomycin (DSM), enrofloxacin (ERFX; Wako) and oxytetracycline (OTC) are used for animal diseases, and the susceptibility of L. monocytogenes have been investigated in the previous studies [1, 2, 6, 17] . Nosiheptide (NHT), salinomycin (SLM) and virginiamycin (VGM) are used as feed additives for livestock. The antibiotics without reference to companies were provided by the National Veterinary Assay Laboratory, Japan. All antibiotics were used in 2-fold serial dilutions. ABPC, CP, EM, GM, KM, and LCM were diluted to concentrations ranging from 0.125 to 16 g/ml; DSM, ERFX, OTC, SLM, VCM, and VGM were diluted to concentrations ranging from 0.125 to 128 g/ml; and NHT was diluted to concentrations ranging from 0.125 to 32 g/ml. The susceptibility tests were performed using the agar dilution method, modifying the method by Lyautey et al. [8] . Briefly, L. monocytogenes cells were grown in BHI broth at 37°C for 24 hr and diluted 1:10 with saline for the antibiotic resistance tests. Bacterial cells were inoculated onto Muller-Hinton agar (Difco Laboratories, Detroit, MI, U.S.A.) plates, which were made with 20 ml of agar solution in 90 mm diameter Petri dishes, by using a MicroPlanter MIT-P multipoint inoculator (SAKUMA, Tokyo, Japan), according to the manufacturer's instructions. The inoculation volume of each spot was 5 l;
therefore, approximately 10 5 Colony Forming Unit per spot were inoculated. All plates were incubated at 37°C. The formation of colonies was observed at 48 hr after inoculation, and the Minimum Inhibitory Concentration (MIC), the MIC for 50% of the strains (MIC 50 ), and the MIC for 90% of the strains (MIC 90 ) were determined for each antibiotic. The breakpoint for the susceptibility of L. monocytogenes to ABPC was obtained from the Clinical and Laboratory Standards Institute guideline, M31-A3 [5] . For the other antibiotics that did not have breakpoints specified in this guideline, and having bimodal MIC distributions, the microbiological breakpoints were applied as well as research results of the Japanese Veterinary Antimicrobial Resistance Monitoring System [21] . The microbiological breakpoint is defined as the intermediate MIC between the 2 peak distributions. When the MIC distribution was monomodal, the breakpoint was not determined.
The MIC distributions of CP (2->16 g/ml), DSM (4-16 g/ml), EM (0.25-1 g/ml), ERFX (0.5-4 g/ml), GM (0.25-2 g/ml), KM (0.5-4 g/ml), LCM (2->16 g/ml), NHT (0.25 g/ml), SNM (0.25-1 g/ml), VCM (0.5-2 g/ ml), and VGM (0.5-4 g/ml) were monomodal, suggesting that all the isolates were susceptible to these antibiotics (Table 2) . ABPC is the most frequently used antibiotic for the treatment of human listeriosis [14] . In our study, all of the isolates were susceptible, and the MIC 50 and MIC 90 values were 0.5 g/ml ( Table 2 ), indicating that the MICs of isolates for ABPC were very low. In previous studies in Japan, there were only 2 reports on ABPC-resistant isolates from human patients. One was from a materno-infant case, and the isolate from the mother showed an MIC of >8 g/ ml. On the other hand, the MIC values of the isolates from blood, stool, ear, pharynx and cerebrospinal fluid of the infant were 0.5 g/ml [22] , suggesting that the ABPC-resistance of the isolate from the mother was acquired after delivery. In another report, 1 of 5 isolates from human patients with cancer, from 1995 to 2007, was ABPC-resistant [16] . In all other papers including this study, concerning the Japanese situation, no resistant isolates were reported. It is considered that ABPC-resistant isolates may be rare in Japan, compared to Turkey [3, 4, 23] or the U.S. [15, 18] , although the reasons are unclear.
The MIC distribution of OTC was bimodal, and the microbiological breakpoint was determined as 16 g/ml (Table 2) . One clinical strain isolated in 1988 was resistant to OTC (MIC=64 g/ml), which belongs to the tetracyclines class of antibiotics and is often used for livestock. In an additional confirmatory test, this isolate showed the same MIC to OTC and a very high MIC (128 g/ml) to tetracycline, belonging to the same group of antibiotics and used for human.
In conclusion, our results indicate that most of these L. monocytogenes isolates from humans and other origins remain susceptible to antibiotics used as drugs for human, animal, or feed additives. Resistance in L. monocytogenes is not critical in Japan at present; however, because antimicrobial chemotherapy is the only available treatment for listeriosis in humans and animals, considered use of antibiotics in veterinary medicine and continuous surveillance of antibiotic susceptibility is essential. 
